↓ Skip to main content

Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: na open-label multicentre randomized controlled” trial (TOCIBRAS)

Overview of attention for article published in Revista Brasileira de Terapia Intensiva, January 2020
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
120 Mendeley